Nanocob-NP Tablet SR
Marketer
Adorfem Cheminnova Life Sciences
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Overview Nanocob-NP Tablet SR
Neuropathic pain relief is provided by the extended-release Nanocob-NP Tablet, a dual-action formulation. Its mechanism involves modulating nerve cell calcium channels to reduce pain signals. Simultaneously, it elevates neurotransmitter levels in the brain, improving mood and safeguarding nerve health. Nanocob-NP Tablet SR may be administered with or without food, but consistent daily timing is recommended for optimal therapeutic blood levels. Always adhere to your physician's prescribed dosage and duration. Missed doses should be taken promptly upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation is discouraged due to potential symptom exacerbation. Common side effects include constipation, weight increase, and dry mouth. Drowsiness and dizziness may occur; avoid activities requiring alertness until the medication's effects are known. Weight gain may be a consequence; a balanced diet and exercise are advised for management. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of all current medications, as interactions may affect efficacy or alter the drug's action. Inform your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Primary Ingredients of Nanocob-NP Tablet SR
No text provided. Please provide the text you wish to be rewritten.
Uses of Nanocob-NP Tablet SR
Managing neuropathic pain
Major Benefits of Nanocob-NP Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Nanocob-NP SR Tablets. Ingest the tablets whole; do not break, crush, or chew them. These tablets can be administered with or without food, but consistent timing is recommended.
Common Side effects of Nanocob-NP Tablet SR:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Difficulty in urination
- Decreased appetite
- Nausea
- Vomiting
- Constipation
- Weight gain
- Dizziness
- Sleepiness
- Tiredness
- Blurred vision
- Dryness in mouth
- Uncoordinated body movements
- Diarrhea
- Headache
How to use Nanocob-NP Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Nanocob-NP Tablet SR should be swallowed whole; do not alter its form by chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended for optimal results.
How Nanocob-NP Tablet SR works:
Nanocob-NP SR tablets combine pregabalin, nortriptyline, and methylcobalamin to alleviate neuropathic pain. Pregabalin, an alpha-2-delta calcium channel modulator, reduces pain transmission in nerve cells. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal transmission within the brain. Methylcobalamin, a B vitamin, promotes myelin production, shielding nerve fibers and aiding in nerve cell repair. This synergistic action targets neuropathic pain stemming from nerve damage.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Nanocob-NP Tablet SR and alcohol may lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Nanocob-NP Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Nanocob-NP tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Nanocob-NP tablets may induce adverse reactions impacting driving ability. This is because Nanocob-NP tablets can reduce alertness, potentially hindering safe driving.
KidneyCAUTION
Patients with kidney impairment should use Nanocob-NP Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Nanocob-NP Tablet SR in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, though further data is limited. Physician consultation is advised.
What if you forget to take Nanocob-NP Tablet SR :
Should you forget a Nanocob-NP Tablet SR dose, administer it at your earliest convenience. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Nanocob-NP Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) |


